Riverstone Holdings: 21.8% Net Profit Growth in 3QFY24 – Investment Analysis

Key Facts for Investor Action

• Revenue increased by 33.9% y-o-y to RM298.4 million for 3QFY24 [[1]].
• Net profit rose 21.8% y-o-y to RM72.2 million for 3QFY24 [[1]].
• Gross profit margin remained flat at 34.7% [[1]].
• Operating profit margin dropped to 30.3% due to foreign exchange loss [[1]].
• Recommended interim dividend of 4.0 sen per ordinary share, total payout ratio at 82.0% [[2]].

Business Description

Riverstone Holdings Limited is a Malaysia-based company that specializes in manufacturing nitrile and natural rubber cleanroom gloves for controlled environments and premium nitrile gloves for the healthcare industry. The company serves global leaders in the HDD, LCD, semiconductor, consumer electronics, pharmaceutical, and healthcare industries. Riverstone employs approximately 3,000 people across its six manufacturing facilities in Malaysia, Thailand, and China [[2]].

Industry Position

Riverstone is a global market leader in its sector. Their proprietary “RS Riverstone Resources” brand is preferred for use in high-tech manufacturing industries. The company faces competition from other manufacturers of cleanroom and healthcare gloves but maintains a competitive advantage through its specialized products and significant production capacity of 10.5 billion gloves annually [[2]].

Revenue Streams and Customer Base

Riverstone generates revenue primarily from the sale of cleanroom and healthcare gloves. Its customers include prominent companies in the semiconductor, electronics, and healthcare industries. The company has a robust supply chain and a global sales network spanning Singapore, Malaysia, Thailand, the Philippines, China, and the U.S. [[2]].

Financial Statement Analysis

Income Statement

Riverstone reported a 33.9% increase in revenue y-o-y to RM298.4 million for 3QFY24. The gross profit rose 33.2% y-o-y to RM103.6 million, while the operating profit margin decreased to 30.3% due to foreign exchange loss [[1]].

Balance Sheet

The report does not provide specific balance sheet details, but the significant revenue growth and stable gross profit margins indicate a strong financial position.

Cash Flow Statement

The report does not provide specific cash flow details. However, the net profit increase and high dividend payout ratio suggest healthy cash flow management.

Dividends

The company declared an interim dividend of 4.0 sen (RM) per ordinary share. Including the 8.0 sen (RM) declared and paid earlier in the year, the total dividend payout ratio stands at 82.0% [[2]].

Key Findings

Strengths:

• Significant revenue and net profit growth.
• Stable gross profit margins.
• Strong dividend payout ratio.
• Leading market position with specialized products.

Risks:

• Operating profit margin affected by foreign exchange losses.
• Dependence on the global semiconductor and healthcare markets.

Special Activities

Riverstone is expanding its production capacity with six new cleanroom lines and six new healthcare lines, three of which will be commissioned by the end of 2024 and the remaining three by 1Q2025 [[2]].

Investment Recommendations

For Current Investors

Hold the stock. Riverstone’s strong financial performance, significant revenue and net profit growth, and high dividend payout ratio make it a valuable investment. The expansion of production capacity is likely to drive future growth.

For Potential Investors

Consider buying the stock. The company’s market leadership, robust financial performance, and strategic expansion plans present a compelling investment opportunity. However, be mindful of potential risks related to foreign exchange losses and market dependence.

Disclaimer: This analysis is based on the financial report provided and does not constitute financial advice. Investors are advised to conduct their own research or consult a financial advisor before making investment decisions.